科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Frontiers in medicine2026-01-01

Chronic thromboembolic pulmonary hypertension: towards an etiology-oriented conceptual framework.

Masayuki Nishiyama, Takayuki Okada, Wakana Teranaka, Takahiko Naruko, Tadaaki Koyama

一句话结论 · In one sentence

CTEPH should be reconsidered as a heterogeneous thrombo-vasculopathic syndrome. An etiology-based framework linking pathobiology, anatomy, and treatment may help explain global practice variation and support phenotype-guided management.

原始摘要(英文原文)· Original abstract
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is traditionally regarded as a late complication of unresolved acute pulmonary embolism. However, this paradigm is challenged by several observations: up to half of patients lack a documented embolic history, distal or microvascular disease is common, and marked geographic differences in treatment strategies exist. While pulmonary endarterectomy (PEA) predominates in Western centers, Japanese programs have advanced balloon pulmonary angioplasty (BPA), particularly for distal disease. These discrepancies suggest that CTEPH represents a biologically heterogeneous condition rather than a post-embolic entity. METHODS AND CONCEPTUAL FRAMEWORK: We developed an etiology-oriented framework integrating pathogenic mechanisms, vascular lesion distribution, and therapeutic strategies. Using Virchow's triad as a structural lens, dominant disease drivers were mapped to distinct phenotypes within a thrombo-vasculopathic spectrum. RESULTS: Five mechanistic phenotypes are proposed: (1) thromboembolism-related (Type Ia), characterized by unresolved embolic obstruction and proximal disease; (2) thrombophilia-associated (Type Ib), driven by systemic hypercoagulability; (3) inflammation- or immune-mediated (Type Ic), associated with endothelial injury and vascular remodeling; (4) structural pulmonary arteriopathy-associated (Type II), in which intrinsic arterial abnormalities precede thrombosis; and (5) idiopathic (Type III), without identifiable cause. These phenotypes form a continuum defined by the relative contributions of thrombotic obstruction and intrinsic vascular remodeling. Within this framework, PEA aligns with proximal disease, whereas BPA and medical therapy correspond to distal vasculopathic phenotypes. CONCLUSION: CTEPH should be reconsidered as a heterogeneous thrombo-vasculopathic syndrome. An etiology-based framework linking pathobiology, anatomy, and treatment may help explain global practice variation and support phenotype-guided management.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Chronic thromboembolic pulmonary hypertension: towards an etiology-oriented conceptual framework. — 科研速览 Science Skim